The Clorox Company (NYSE: CLX) Stock Competitors & Peer Comparison
See CLX's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CLX and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CLX | $105.70 | -0.79% | 12.8B | 19.08 | $5.54 | +4.72% |
| PG | $144.55 | +0.20% | 343.6B | 20.83 | $6.94 | +2.97% |
| UL | $62.09 | -0.94% | 133.8B | 20.42 | $3.04 | +3.57% |
| CL | $91.95 | -1.05% | 73.6B | 24.52 | $3.75 | +2.29% |
| KVUE | $19.20 | +0.00% | 36.8B | 16.26 | $1.18 | +4.33% |
| KMB | $110.39 | -0.28% | 36.6B | 14.82 | $7.45 | +4.60% |
| EL | $86.10 | -1.40% | 31.1B | 38.95 | $2.21 | +1.62% |
| CHD | $101.30 | -0.02% | 24B | 28.46 | $3.56 | +1.21% |
| REYN | $26.25 | -0.23% | 5.5B | 15.35 | $1.71 | +3.51% |
| ELF | $91.44 | -0.66% | 5.4B | 22.93 | $3.99 | N/A |
Stock Comparison
The Procter & Gamble Company (NYSE: PG)
CLX vs PG Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, PG has a market cap of 343.6B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while PG trades at $144.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas PG's P/E ratio is 20.83. In terms of profitability, CLX's ROE is -18.94%, compared to PG's ROE of +0.30%. Regarding short-term risk, CLX is more volatile compared to PG. This indicates higher risk in terms of short-term price fluctuations for CLX.Check PG's competition here
Unilever PLC (NYSE: UL)
CLX vs UL Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, UL has a market cap of 133.8B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while UL trades at $62.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas UL's P/E ratio is 20.42. In terms of profitability, CLX's ROE is -18.94%, compared to UL's ROE of +0.36%. Regarding short-term risk, CLX is more volatile compared to UL. This indicates higher risk in terms of short-term price fluctuations for CLX.Check UL's competition here
Colgate-Palmolive Company (NYSE: CL)
CLX vs CL Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, CL has a market cap of 73.6B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while CL trades at $91.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas CL's P/E ratio is 24.52. In terms of profitability, CLX's ROE is -18.94%, compared to CL's ROE of +6.31%. Regarding short-term risk, CLX is more volatile compared to CL. This indicates higher risk in terms of short-term price fluctuations for CLX.Check CL's competition here
Kenvue Inc. (NYSE: KVUE)
CLX vs KVUE Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, KVUE has a market cap of 36.8B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while KVUE trades at $19.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas KVUE's P/E ratio is 16.26. In terms of profitability, CLX's ROE is -18.94%, compared to KVUE's ROE of +0.16%. Regarding short-term risk, CLX is more volatile compared to KVUE. This indicates higher risk in terms of short-term price fluctuations for CLX.Check KVUE's competition here
Kimberly-Clark Corporation (NASDAQ: KMB)
CLX vs KMB Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, KMB has a market cap of 36.6B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while KMB trades at $110.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas KMB's P/E ratio is 14.82. In terms of profitability, CLX's ROE is -18.94%, compared to KMB's ROE of +1.23%. Regarding short-term risk, CLX is more volatile compared to KMB. This indicates higher risk in terms of short-term price fluctuations for CLX.Check KMB's competition here
The Estée Lauder Companies Inc. (NYSE: EL)
CLX vs EL Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, EL has a market cap of 31.1B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while EL trades at $86.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas EL's P/E ratio is 38.95. In terms of profitability, CLX's ROE is -18.94%, compared to EL's ROE of -0.06%. Regarding short-term risk, CLX is more volatile compared to EL. This indicates higher risk in terms of short-term price fluctuations for CLX.Check EL's competition here
Church & Dwight Co., Inc. (NYSE: CHD)
CLX vs CHD Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, CHD has a market cap of 24B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while CHD trades at $101.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas CHD's P/E ratio is 28.46. In terms of profitability, CLX's ROE is -18.94%, compared to CHD's ROE of +0.18%. Regarding short-term risk, CLX is more volatile compared to CHD. This indicates higher risk in terms of short-term price fluctuations for CLX.Check CHD's competition here
Reynolds Consumer Products Inc. (NASDAQ: REYN)
CLX vs REYN Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, REYN has a market cap of 5.5B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while REYN trades at $26.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas REYN's P/E ratio is 15.35. In terms of profitability, CLX's ROE is -18.94%, compared to REYN's ROE of +0.15%. Regarding short-term risk, CLX is more volatile compared to REYN. This indicates higher risk in terms of short-term price fluctuations for CLX.Check REYN's competition here
e.l.f. Beauty, Inc. (NYSE: ELF)
CLX vs ELF Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, ELF has a market cap of 5.4B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while ELF trades at $91.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas ELF's P/E ratio is 22.93. In terms of profitability, CLX's ROE is -18.94%, compared to ELF's ROE of +0.05%. Regarding short-term risk, CLX is less volatile compared to ELF. This indicates lower risk in terms of short-term price fluctuations for CLX.Check ELF's competition here
Natura &Co Holding S.A. (NYSE: NTCO)
CLX vs NTCO Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas NTCO's P/E ratio is -11.37. In terms of profitability, CLX's ROE is -18.94%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, CLX is less volatile compared to NTCO. This indicates lower risk in terms of short-term price fluctuations for CLX.Check NTCO's competition here
Inter Parfums, Inc. (NASDAQ: IPAR)
CLX vs IPAR Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, IPAR has a market cap of 3.7B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while IPAR trades at $114.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas IPAR's P/E ratio is 21.92. In terms of profitability, CLX's ROE is -18.94%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, CLX is less volatile compared to IPAR. This indicates lower risk in terms of short-term price fluctuations for CLX.Check IPAR's competition here
Central Garden & Pet Company (NASDAQ: CENT)
CLX vs CENT Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, CENT has a market cap of 2.7B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while CENT trades at $43.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas CENT's P/E ratio is 14.82. In terms of profitability, CLX's ROE is -18.94%, compared to CENT's ROE of +0.10%. Regarding short-term risk, CLX is less volatile compared to CENT. This indicates lower risk in terms of short-term price fluctuations for CLX.Check CENT's competition here
Newell Brands Inc. (NASDAQ: NWL)
CLX vs NWL Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, NWL has a market cap of 2.7B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while NWL trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas NWL's P/E ratio is 11.56. In terms of profitability, CLX's ROE is -18.94%, compared to NWL's ROE of -0.09%. Regarding short-term risk, CLX is less volatile compared to NWL. This indicates lower risk in terms of short-term price fluctuations for CLX.Check NWL's competition here
Coty Inc. (NYSE: COTY)
CLX vs COTY Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, COTY has a market cap of 2.5B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while COTY trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas COTY's P/E ratio is 15.81. In terms of profitability, CLX's ROE is -18.94%, compared to COTY's ROE of -0.15%. Regarding short-term risk, CLX is less volatile compared to COTY. This indicates lower risk in terms of short-term price fluctuations for CLX.Check COTY's competition here
Spectrum Brands Holdings, Inc. (NYSE: SPB)
CLX vs SPB Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, SPB has a market cap of 2.1B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while SPB trades at $89.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas SPB's P/E ratio is 13.83. In terms of profitability, CLX's ROE is -18.94%, compared to SPB's ROE of +0.04%. Regarding short-term risk, CLX is less volatile compared to SPB. This indicates lower risk in terms of short-term price fluctuations for CLX.Check SPB's competition here
Edgewell Personal Care Company (NYSE: EPC)
CLX vs EPC Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while EPC trades at $28.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas EPC's P/E ratio is 15.45. In terms of profitability, CLX's ROE is -18.94%, compared to EPC's ROE of -0.06%. Regarding short-term risk, CLX is less volatile compared to EPC. This indicates lower risk in terms of short-term price fluctuations for CLX.Check EPC's competition here
Oddity Tech Ltd. (NASDAQ: ODD)
CLX vs ODD Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, ODD has a market cap of 747.2M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while ODD trades at $13.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas ODD's P/E ratio is 10.08. In terms of profitability, CLX's ROE is -18.94%, compared to ODD's ROE of +0.14%. Regarding short-term risk, CLX is less volatile compared to ODD. This indicates lower risk in terms of short-term price fluctuations for CLX.Check ODD's competition here
Helen of Troy Limited (NASDAQ: HELE)
CLX vs HELE Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, HELE has a market cap of 703.9M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while HELE trades at $30.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas HELE's P/E ratio is 9.16. In terms of profitability, CLX's ROE is -18.94%, compared to HELE's ROE of -0.48%. Regarding short-term risk, CLX is less volatile compared to HELE. This indicates lower risk in terms of short-term price fluctuations for CLX.Check HELE's competition here
The Honest Company, Inc. (NASDAQ: HNST)
CLX vs HNST Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, HNST has a market cap of 532.8M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while HNST trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas HNST's P/E ratio is 75.87. In terms of profitability, CLX's ROE is -18.94%, compared to HNST's ROE of -0.07%. Regarding short-term risk, CLX is less volatile compared to HNST. This indicates lower risk in terms of short-term price fluctuations for CLX.Check HNST's competition here
Magnera Corp (NYSE: MAGN)
CLX vs MAGN Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, MAGN has a market cap of 444.3M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while MAGN trades at $12.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas MAGN's P/E ratio is -6.04. In terms of profitability, CLX's ROE is -18.94%, compared to MAGN's ROE of -0.11%. Regarding short-term risk, CLX is less volatile compared to MAGN. This indicates lower risk in terms of short-term price fluctuations for CLX.Check MAGN's competition here
European Wax Center, Inc. (NASDAQ: EWCZ)
CLX vs EWCZ Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, CLX's ROE is -18.94%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, CLX is more volatile compared to EWCZ. This indicates higher risk in terms of short-term price fluctuations for CLX.Check EWCZ's competition here
Yatsen Holding Limited (NYSE: YSG)
CLX vs YSG Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, YSG has a market cap of 316.9M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while YSG trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas YSG's P/E ratio is -26.45. In terms of profitability, CLX's ROE is -18.94%, compared to YSG's ROE of -0.05%. Regarding short-term risk, CLX is less volatile compared to YSG. This indicates lower risk in terms of short-term price fluctuations for CLX.Check YSG's competition here
USANA Health Sciences, Inc. (NYSE: USNA)
CLX vs USNA Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, USNA has a market cap of 246.5M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while USNA trades at $13.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas USNA's P/E ratio is 13.48. In terms of profitability, CLX's ROE is -18.94%, compared to USNA's ROE of -0.04%. Regarding short-term risk, CLX is less volatile compared to USNA. This indicates lower risk in terms of short-term price fluctuations for CLX.Check USNA's competition here
Nu Skin Enterprises, Inc. (NYSE: NUS)
CLX vs NUS Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, NUS has a market cap of 233.3M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while NUS trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas NUS's P/E ratio is 4.00. In terms of profitability, CLX's ROE is -18.94%, compared to NUS's ROE of -0.29%. Regarding short-term risk, CLX is less volatile compared to NUS. This indicates lower risk in terms of short-term price fluctuations for CLX.Check NUS's competition here
Acme United Corporation (AMEX: ACU)
CLX vs ACU Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, ACU has a market cap of 231.8M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while ACU trades at $60.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas ACU's P/E ratio is 26.22. In terms of profitability, CLX's ROE is -18.94%, compared to ACU's ROE of +0.08%. Regarding short-term risk, CLX is less volatile compared to ACU. This indicates lower risk in terms of short-term price fluctuations for CLX.Check ACU's competition here
Pitanium Limited (NASDAQ: PTNM)
CLX vs PTNM Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas PTNM's P/E ratio is 346.33. In terms of profitability, CLX's ROE is -18.94%, compared to PTNM's ROE of -0.99%. Regarding short-term risk, CLX is more volatile compared to PTNM. This indicates higher risk in terms of short-term price fluctuations for CLX.Check PTNM's competition here
Waldencast plc (NASDAQ: WALD)
CLX vs WALD Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, WALD has a market cap of 159.6M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while WALD trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas WALD's P/E ratio is -2.25. In terms of profitability, CLX's ROE is -18.94%, compared to WALD's ROE of -0.48%. Regarding short-term risk, CLX is less volatile compared to WALD. This indicates lower risk in terms of short-term price fluctuations for CLX.Check WALD's competition here
Waldencast plc (NASDAQ: WALDW)
CLX vs WALDW Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, WALDW has a market cap of 149.1M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while WALDW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas WALDW's P/E ratio is -0.05. In terms of profitability, CLX's ROE is -18.94%, compared to WALDW's ROE of -0.48%. Regarding short-term risk, CLX is less volatile compared to WALDW. This indicates lower risk in terms of short-term price fluctuations for CLX.Check WALDW's competition here
Solesence, Inc. Common Stock (NASDAQ: SLSN)
CLX vs SLSN Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, SLSN has a market cap of 73.5M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while SLSN trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas SLSN's P/E ratio is 84.55. In terms of profitability, CLX's ROE is -18.94%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, CLX is less volatile compared to SLSN. This indicates lower risk in terms of short-term price fluctuations for CLX.Check SLSN's competition here
Upexi, Inc. (NASDAQ: UPXI)
CLX vs UPXI Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, UPXI has a market cap of 54.9M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while UPXI trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas UPXI's P/E ratio is -0.17. In terms of profitability, CLX's ROE is -18.94%, compared to UPXI's ROE of -3.07%. Regarding short-term risk, CLX is less volatile compared to UPXI. This indicates lower risk in terms of short-term price fluctuations for CLX.Check UPXI's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV)
CLX vs GROV Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, GROV has a market cap of 43.7M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while GROV trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas GROV's P/E ratio is -4.00. In terms of profitability, CLX's ROE is -18.94%, compared to GROV's ROE of -0.83%. Regarding short-term risk, CLX is less volatile compared to GROV. This indicates lower risk in terms of short-term price fluctuations for CLX.Check GROV's competition here
Axil Brands, Inc. (AMEX: AXIL)
CLX vs AXIL Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, AXIL has a market cap of 41.5M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while AXIL trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas AXIL's P/E ratio is 50.71. In terms of profitability, CLX's ROE is -18.94%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, CLX is less volatile compared to AXIL. This indicates lower risk in terms of short-term price fluctuations for CLX.Check AXIL's competition here
United-Guardian, Inc. (NASDAQ: UG)
CLX vs UG Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, UG has a market cap of 32.8M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while UG trades at $7.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas UG's P/E ratio is 13.71. In terms of profitability, CLX's ROE is -18.94%, compared to UG's ROE of +0.22%. Regarding short-term risk, CLX is less volatile compared to UG. This indicates lower risk in terms of short-term price fluctuations for CLX.Check UG's competition here
Big Tree Cloud Holdings Limited (NASDAQ: DSY)
CLX vs DSY Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, DSY has a market cap of 20.2M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while DSY trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas DSY's P/E ratio is -0.47. In terms of profitability, CLX's ROE is -18.94%, compared to DSY's ROE of +14.77%. Regarding short-term risk, CLX is less volatile compared to DSY. This indicates lower risk in terms of short-term price fluctuations for CLX.Check DSY's competition here
Mannatech, Incorporated (NASDAQ: MTEX)
CLX vs MTEX Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, MTEX has a market cap of 12M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while MTEX trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas MTEX's P/E ratio is -0.93. In terms of profitability, CLX's ROE is -18.94%, compared to MTEX's ROE of +3.37%. Regarding short-term risk, CLX is less volatile compared to MTEX. This indicates lower risk in terms of short-term price fluctuations for CLX.Check MTEX's competition here
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH)
CLX vs PHH Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, PHH has a market cap of 10M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas PHH's P/E ratio is -0.53. In terms of profitability, CLX's ROE is -18.94%, compared to PHH's ROE of +0.38%. Regarding short-term risk, CLX is less volatile compared to PHH. This indicates lower risk in terms of short-term price fluctuations for CLX.Check PHH's competition here
Bruush Oral Care Inc. (NASDAQ: BRSH)
CLX vs BRSH Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas BRSH's P/E ratio is -0.01. In terms of profitability, CLX's ROE is -18.94%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, CLX is less volatile compared to BRSH. This indicates lower risk in terms of short-term price fluctuations for CLX.Check BRSH's competition here
Tantech Holdings Ltd (NASDAQ: TANH)
CLX vs TANH Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, TANH has a market cap of 5.7M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while TANH trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas TANH's P/E ratio is 0.04. In terms of profitability, CLX's ROE is -18.94%, compared to TANH's ROE of -0.25%. Regarding short-term risk, CLX is less volatile compared to TANH. This indicates lower risk in terms of short-term price fluctuations for CLX.Check TANH's competition here
Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ: BYAH)
CLX vs BYAH Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, BYAH has a market cap of 2.5M. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while BYAH trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas BYAH's P/E ratio is N/A. In terms of profitability, CLX's ROE is -18.94%, compared to BYAH's ROE of -1.74%. Regarding short-term risk, CLX is less volatile compared to BYAH. This indicates lower risk in terms of short-term price fluctuations for CLX.Check BYAH's competition here
Bruush Oral Care Inc. (NASDAQ: BRSHW)
CLX vs BRSHW Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas BRSHW's P/E ratio is N/A. In terms of profitability, CLX's ROE is -18.94%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, CLX is less volatile compared to BRSHW. This indicates lower risk in terms of short-term price fluctuations for CLX.Check BRSHW's competition here
Elizabeth Arden, Inc. (NASDAQ: RDEN)
CLX vs RDEN Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, RDEN has a market cap of 0. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas RDEN's P/E ratio is -5.68. In terms of profitability, CLX's ROE is -18.94%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, CLX is more volatile compared to RDEN. This indicates higher risk in terms of short-term price fluctuations for CLX.Check RDEN's competition here
Revlon, Inc. (NYSE: REV)
CLX vs REV Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, REV has a market cap of 0. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas REV's P/E ratio is -1.19. In terms of profitability, CLX's ROE is -18.94%, compared to REV's ROE of +0.89%. Regarding short-term risk, CLX is less volatile compared to REV. This indicates lower risk in terms of short-term price fluctuations for CLX.Check REV's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV-WT)
CLX vs GROV-WT Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, CLX's ROE is -18.94%, compared to GROV-WT's ROE of -0.83%. Regarding short-term risk, CLX is more volatile compared to GROV-WT. This indicates higher risk in terms of short-term price fluctuations for CLX.Check GROV-WT's competition here
Summer Infant, Inc. (NASDAQ: SUMR)
CLX vs SUMR Comparison August 2026
The Clorox Company (NYSE: CLX) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLX stands at 12.8B. In comparison, SUMR has a market cap of 0. Regarding current trading prices, CLX is priced at $105.70 on the NYSE, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLX currently has a P/E ratio of 19.08, whereas SUMR's P/E ratio is -3.66. In terms of profitability, CLX's ROE is -18.94%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, CLX is more volatile compared to SUMR. This indicates higher risk in terms of short-term price fluctuations for CLX.Check SUMR's competition here